.
BioEnterprise

Mercury Biomed

Mercury Biomed is commercializing novel and proprietary technology to safely and effectively adjust and maintain a patient’s core body temperature. Its WarmSmart and SmartCool products are currently in clinical trials and are targeted for launch in 2016 and 2018, respectively, pending FDA 510 (k) clearances.

Stage

Clinical
Hello. Add your message here.